Mitophagy and NAD+ inhibit Alzheimer disease

Autophagy

Volumn 15, Issue 6, 2019, Pages 1112-1114

  Fang, Evandro F ^a  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

aging; Alzheimer s disease; memory; mitochondria; Mitophagy

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; NICOTINAMIDE ADENINE DINUCLEOTIDE; PDR 1 PROTEIN; PINK 1 PROTEIN; PROTEIN; SIRTUIN 1; SIRTUIN 3; SIRTUIN 4; SIRTUIN 5; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AUTOPHOSPHORYLATION; COGNITIVE DEFECT; DRUG MECHANISM; GENE KNOCKOUT; GENE MUTATION; HEREDITY; HUMAN; MITOCHONDRION; MITOPHAGY; NONHUMAN; NOTE; ANIMAL; AUTOPHAGY; COGNITION;

ALZHEIMER DISEASE; ANIMALS; AUTOPHAGY; COGNITION; HUMANS; MITOPHAGY; NAD;

EID: 85063584691     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.1080/15548627.2019.1596497     Document Type: Note

References (1)

1. Fang, EF, Huo Y, Palikaras K, et al. Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease. Nat Neurosci. 2019;22(3):401–412.